ESMO – European Society for Medical Oncology — shared on LinkedIn:
“ESMOGynae25: Advance your practice and make a meaningful impact in the lives of women with gynaecological cancers.
Register before 21 May to get advantageous fees and connect with renowned oncologists, surgeons, researchers, and other professionals that are shaping the future of this field.
Learning Objectives:
-
To provide updates on state-of-the-art management of patients with gynaecological cancers
-
To highlight the scientific advances in profiling, risk stratification and therapeutic options for the optimal care of patients with gynaecological cancers
-
To highlight biomarkers applicable for precision medicine in patients with gynaecological cancers.”
Find More Posts Featuring ESMO on OncoDaily.